Peroxisome proliferator-activated receptor-gamma agonists prevent experimental autoimmune encephalomyelitis. - Wikidata - wikimedia - TriplyDB

Peroxisome proliferator-activated receptor-gamma agonists prevent experimental autoimmune encephalomyelitis.

Peroxisome proliferator-activated receptor-gamma agonists prevent experimental autoimmune encephalomyelitis.

http://www.wikidata.org/entity/Q44060078

about

PPAR-gamma: Therapeutic Potential for Multiple Sclerosis The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies Effect of pioglitazone treatment in a patient with secondary multiple sclerosis Effect of anti-inflammatory agents on transforming growth factor beta over-expressing mouse brains: a model revised Importance of Apolipoprotein A-I in Multiple Sclerosis PPAR-γ -- a possible drug target for complicated pregnancies Crystallographic studies of human MitoNEET PPARγ as a therapeutic target to rescue mitochondrial function in neurological disease A cannabigerol derivative suppresses immune responses and protects mice from experimental autoimmune encephalomyelitis Cardioprotective effects of peroxisome proliferator activated receptor gamma activators on acute myocarditis: anti-inflammatory actions associated with nuclear factor kappaB blockade Suppression of neuroinflammation in forebrain-specific Cdk5 conditional knockout mice by PPARγ agonist improves neuronal loss and early lethality Regulation of oligodendrocyte progenitor cell maturation by PPARδ: effects on bone morphogenetic proteins Cyclopentenone prostaglandins PGA2 and 15-deoxy-delta12,14 PGJ2 suppress activation of murine microglia and astrocytes: implications for multiple sclerosis.Nuclear receptors and autoimmune disease: the potential of PPAR agonists to treat multiple sclerosis.9-Cis-retinoic acid suppresses inflammatory responses of microglia and astrocytes.Oxaliplatin neurotoxicity involves peroxisome alterations. PPARγ agonism as preventive pharmacological approach.Impaired clearance of apoptotic cells in chronic inflammatory diseases: therapeutic implications Peroxisome proliferator-activated receptor delta limits the expansion of pathogenic Th cells during central nervous system autoimmunity Chronic immobilisation stress ameliorates clinical score and neuroinflammation in a MOG-induced EAE in Dark Agouti rats: mechanisms implicated.A cannabigerol quinone alleviates neuroinflammation in a chronic model of multiple sclerosis.Regulation of Immune Responses and Autoimmune Encephalomyelitis by PPARs.Expression of peroxisome proliferator-activated receptor-gamma in the substantia nigra of hemiparkinsonian nonhuman primates PPARgamma and PPARdelta negatively regulate specific subsets of lipopolysaccharide and IFN-gamma target genes in macrophages The PPAR-γ agonist pioglitazone modulates inflammation and induces neuroprotection in parkinsonian monkeys.Peroxisome proliferator-activated receptor gamma is required for CD4+ T cell-mediated lymphopenia-associated autoimmunity.Targeting epidermal fatty acid binding protein for treatment of experimental autoimmune encephalomyelitis.Broad-spectrum neuroprotection against traumatic brain injury by agonism of peroxisome proliferator-activated receptors A Sativex(®) -like combination of phytocannabinoids as a disease-modifying therapy in a viral model of multiple sclerosis.Modulation of macrophage efferocytosis in inflammation.The PPAR gamma agonist Pioglitazone improves anatomical and locomotor recovery after rodent spinal cord injury.Pioglitazone halts axonal degeneration in a mouse model of X-linked adrenoleukodystrophy Development of a high throughput drug screening assay to identify compounds that protect oligodendrocyte viability and differentiation under inflammatory conditions Liver X receptor and retinoid X receptor agonists inhibit inflammatory responses of microglia and astrocytes.Immunopathogenesis and immunotherapeutic approaches in multiple sclerosis.Pioglitazone attenuates acute cocaine toxicity in rat isolated heart: potential protection by metabolic modulation.Combinatorial roles of nuclear receptors in inflammation and immunity.Peroxisome proliferator-activated receptor-gamma agonists suppress the production of IL-12 family cytokines by activated glia.Obeticholic acid, a synthetic bile acid agonist of the farnesoid X receptor, attenuates experimental autoimmune encephalomyelitis.The synthetic peroxisome proliferator-activated receptor-gamma agonist ciglitazone attenuates neuroinflammation and accelerates encapsulation in bacterial brain abscesses.The periodontal host response with diabetes.

P2860

Q21342822-E49F9A5D-A9FC-405D-B298-F091F241C084 Q24646616-5EA7BCE3-FC78-430C-B244-D79D93C87D21 Q24794380-4D2712B9-61E9-414D-BDBA-BF6E7B3E9FEF Q24796292-15081C37-4175-4C2B-89B9-D2AE7A9AF54D Q26774792-ACD8D519-3C31-4AF8-B2BE-0192CDD6007E Q26863678-FED21CB1-15CA-48C2-AA3A-6E6BEED5E9C5 Q27648680-B53B1234-750E-46D0-BA64-5C4CFC1B5B7B Q28069549-BEC6C74C-304A-4DB8-A32E-0080C49472F1 Q28537808-9FAEC27F-4289-4BB4-8C6A-FC7F156B59BE Q28570331-CF28A07D-E827-4FD8-8E16-4A536479C091 Q30572403-F822E577-D901-4B7A-9DD0-5ACD41A5A65F Q33595538-26E91391-0478-4B89-A6E9-62E05BDC9161 Q33644063-F89A7F35-29BA-4D5B-A763-CCCF6F01CD33 Q33644094-57517869-76B7-46D1-A93F-4A0F0F2B5489 Q33674869-D48C9673-B0FC-4E81-BB23-84602655DE3D Q33921641-16F50129-2159-4EC9-A106-920F3D30E2D5 Q33984427-2515E88A-73C7-48F7-99A2-92C6B7D07941 Q34044412-BC5E5184-C2FA-4F1D-896F-BCE57630A76B Q34220882-241F3508-33A0-481B-A1F6-FEBB02EA04F8 Q34299290-F0DD0EDA-718C-45DF-ABCB-15A041CE527C Q34460512-B571B313-260D-4619-9678-8DFAADE637FB Q34626758-230E2624-6F1C-4A40-A6F2-EBF03FABB844 Q35144057-E648DD86-E5BA-42C6-8A27-DDAAC2A84849 Q35196195-718E409A-74AA-4C7A-A3F3-1BC618C55753 Q35293454-11653729-AEB0-44C6-9D4A-A7128FBDAB52 Q35595092-5B22D95C-14D9-4049-AD90-DA4C86CD4AB4 Q35603688-04EB6C1F-CB4D-4394-BFCA-4F28FB300E40 Q35865445-CA541255-AB66-4C15-BC0C-9EECBD13D38B Q35927561-17BAAABF-7A4D-4911-8838-4B057BDC13DA Q35944730-74BE4B3A-A76C-4545-A46E-1F0760061940 Q35997389-560879CF-E57E-4DCE-8BFF-678B9DEF78EE Q36133389-3E676A27-0729-40BC-86A7-EA6CAE80E350 Q36148455-1B4F355A-1F49-40E3-A52B-A8071FE39368 Q36153387-5858A687-E9A1-4569-842C-9904F206ADC1 Q36172303-1E4F8526-5E7B-4CBB-9928-8D7B66F64128 Q36403404-712AC6A8-EECA-4379-993C-8252CA645B5A Q36528985-A0E8D3B4-C2EE-44A2-A145-0FE19F81C922 Q36598778-66211399-8E34-44FC-8DC6-4ABED6DE6211 Q36676619-0CB1B55B-4C19-47C1-AD54-71A4A81304A2 Q36703970-B2D37F51-44DF-4EAB-BF6E-0AB623672B34

P2860

Peroxisome proliferator-activated receptor-gamma agonists prevent experimental autoimmune encephalomyelitis.

http://www.wikidata.org/entity/Q44060078

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh

2002年學術文章

@zh-hant

name

Peroxisome proliferator-activa ...... autoimmune encephalomyelitis.

@en

Peroxisome proliferator-activa ...... autoimmune encephalomyelitis.

@nl

type

label

Peroxisome proliferator-activa ...... autoimmune encephalomyelitis.

@en

Peroxisome proliferator-activa ...... autoimmune encephalomyelitis.

@nl

prefLabel

Peroxisome proliferator-activa ...... autoimmune encephalomyelitis.

@en

Peroxisome proliferator-activa ...... autoimmune encephalomyelitis.

@nl

P1433

Q44060078-901F8B8C-F520-47A3-8F6F-27B2AEDDB56D

P1476

Q44060078-3A5F8364-E286-4333-9D6C-7BBD45D58C3A

P2093

Q44060078-06670341-AD01-487F-A82C-42B4CAC6A769

Q44060078-0AF1E701-CAAD-456F-8C08-13D596E2DDC9

Q44060078-265F598A-0B2E-4058-A201-18E9845107DF

Q44060078-29FA2FF2-5914-4718-BDC4-1081A7E8034E

Q44060078-4ED4D88A-1C51-4B2B-BE87-B5EAB53A82BF

Q44060078-6BC852B7-0B4B-4AB0-A463-310B0ACDAC33

Q44060078-A321CC91-479B-4799-BD86-3435AF89829F

Q44060078-D2958B9A-D0C9-41E8-A3E8-A2B80275F643

Q44060078-E415577A-05B1-47A3-A135-1E09EEC2E2A8

Q44060078-FD5545CF-1FEB-46DD-93D1-767EFDF4DE6D

P2860

Q44060078-20B6783B-D7F1-47B4-8A58-7D11DBE2D8D5

Q44060078-213658DA-DF95-413D-B0D2-BF32AB6920CB

Q44060078-28C4C4A1-1FC6-4A03-87DC-6CF464CAB657

Q44060078-3A860D5C-09C0-4CCA-AA8D-1FEAB8653EC7

Q44060078-4EAC55E2-1E53-403A-BBC1-8590304144D3

Q44060078-52D0D55A-F97B-4AA6-96E6-1863DBA9E6FE

Q44060078-589FC49D-B60B-4C2E-B400-2C9C4679B356

Q44060078-5B5E1EA4-E948-49DB-8D21-AC8C1F94F36C

Q44060078-60F71A49-EBC2-4093-AAE5-D8416F5738B1

Q44060078-64DB8E56-5B1B-4B51-BD21-FA4D60107908

P304

Q44060078-D0BAF586-F138-4D3B-BE89-A221DE0F12B7

P31

Q44060078-4AF44353-3836-4566-918A-79F012B7C6F4

P356

Q44060078-4346C27A-6C49-4C87-9CE0-5330C644828F

P433

Q44060078-50A68B13-08D0-4C55-B06F-08229D213E9C

P478

Q44060078-813A2122-1119-4DF6-86A1-FCDDD06057E0

P577

Q44060078-A4D21443-B857-4D68-9DA6-897D05E83FD3

P698

Q44060078-3F0C9F1A-6DD2-4936-A3F6-F445326E49B9

P921

Q44060078-2ABCFC8C-D867-44BF-A980-3946DDB4D038

P356

P1433

Annals of Neurology

P1476

Peroxisome proliferator-activa ...... autoimmune encephalomyelitis.

@en

P2093

Caroline C Whitacre

http://www.w3.org/2001/XMLSchema#string

Celia F Brosnan

http://www.w3.org/2001/XMLSchema#string

Douglas L Feinstein

http://www.w3.org/2001/XMLSchema#string

Elena Galea

http://www.w3.org/2001/XMLSchema#string

Gary E Landreth

http://www.w3.org/2001/XMLSchema#string

Guy Weinberg

http://www.w3.org/2001/XMLSchema#string

Harrihar A Pershadsingh

http://www.w3.org/2001/XMLSchema#string

Lucia Dumitrescu-Ozimek

http://www.w3.org/2001/XMLSchema#string

Michael T Heneka

http://www.w3.org/2001/XMLSchema#string

Vitaliy Gavrilyuk

http://www.w3.org/2001/XMLSchema#string

P2860

The PPARs: from orphan receptors to drug discovery

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

Endogenous PPAR gamma mediates anti-inflammatory activity in murine ischemia-reperfusion injury.

Expression of peroxisome proliferator-activated receptors (PPARS) in human astrocytic cells: PPARgamma agonists as inducers of apoptosis.

Immunologic therapy of multiple sclerosis.

Treatment of multiple sclerosis: recent trials and future perspectives.

A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response

Tumour necrosis factor and anti-tumour necrosis factor approach to inflammatory demyelinating diseases of the central nervous system.

Evaluation of mitoxantrone for the treatment of multiple sclerosis.

P304

694-702

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ANA.10206

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

51

http://www.w3.org/2001/XMLSchema#string

P577

2002-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12112074

http://www.w3.org/2001/XMLSchema#string

P921

experimental autoimmune encephalomyelitis